Point in time view as at 08/12/2017.
The Risk Transformation Regulations 2017, Section 169 is up to date with all changes known to be in force on or before 05 March 2025. There are changes that may be brought into force at a future date. Changes that have been made appear in the content and are referenced with annotations.
169.—(1) Except to the extent provided for in this Chapter—
(a)a protected cell company may not propose a voluntary arrangement;
(b)neither a protected cell company nor a part of a protected cell company may be placed into administration;
(c)a receiver (including an administrative receiver) may not be appointed in respect of any property held by the protected cell company;
(d)a protected cell company may not pass a resolution for the winding up of the protected cell company or any part of the protected cell company;
(e)a winding-up order may not be made against the protected cell company or any part of the protected cell company;
(f)the estate of a protected cell company or any part of a protected cell company may not be sequestrated under section 6 of the Bankruptcy (Scotland) Act 2016;
(g)neither the protected cell company nor a part of the protected cell company may be subject to any other process under the insolvency legislation which applies to a person who is insolvent or who is likely to become insolvent M1.
(2) The reference in paragraph (1)(d) to winding up includes a reference to a members' voluntary winding up under Chapter 3 of Part 4 of the Insolvency Act 1986 or Chapter 3 of Part 5 of the Insolvency (Northern Ireland) Order 1989.
Marginal Citations
M1Note that a protected cell company is not an “insurer” for the purposes of Part 24 of FSMA because it does not carry on the activity specified in Article 10 of the Regulated Activities Order. See the Financial Services and Markets Act 2000 (Insolvency) (Definition of “Insurer”) Order 2001 (S.I. 2001/2634 amended by S.I. 2002/1242).
All content is available under the Open Government Licence v3.0 except where otherwise stated. This site additionally contains content derived from EUR-Lex, reused under the terms of the Commission Decision 2011/833/EU on the reuse of documents from the EU institutions. For more information see the EUR-Lex public statement on re-use.
